Episurf Medical received a Notice of Allowance from the Korean Intellectual Property Office, affirming the company’s first patent approval in Korea. The patent, “System and method for creating a decision support material indicating damage to an anatomical joint,” covers Episurf Medical’s 3D-based damage marking technology, a central part of the Episealer® implant system as well as the Epioscopy® joint visualization system.
“This is a core patent for Episurf’s imaging technology. We are working towards being able to launch our products in certain Asian markets and maintaining a strong IP portfolio in relevant regions is an important part of that strategy,” said Katarina Flodström, COO.
Episurf Medical received a Notice of Allowance from the Korean Intellectual Property Office, affirming the company’s first patent approval in Korea. The patent, “System and method for creating a decision support material indicating damage to an anatomical joint,” covers Episurf Medical’s 3D-based damage marking technology, a central part of...
Episurf Medical received a Notice of Allowance from the Korean Intellectual Property Office, affirming the company’s first patent approval in Korea. The patent, “System and method for creating a decision support material indicating damage to an anatomical joint,” covers Episurf Medical’s 3D-based damage marking technology, a central part of the Episealer® implant system as well as the Epioscopy® joint visualization system.
“This is a core patent for Episurf’s imaging technology. We are working towards being able to launch our products in certain Asian markets and maintaining a strong IP portfolio in relevant regions is an important part of that strategy,” said Katarina Flodström, COO.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
